Summary
A ONCE-a-day pill that may revolutionise the treatment of breast cancer could also be used to tackle other forms of the disease.
GlaxoSmithKline unveiled plans to trial Tykerb on patients with head and neck cancer, which kills 40,000 people annually in Europe.See the full content of this document
Extract
Cancer Pill Promise
'Having alread...
See the full content of this document
Sponsored links
